|
|
||||||||
Biology of Reproduction, Vol 21, 1035-1042, Copyright © 1979 by Society for the Study of Reproduction
1 Department of Physiology and Department of Obstetrics and Gynaecology,
University of Western Ontario,
London, Ontario, Canada N6A 5A5 Immature female rats were sacrificed at 0, 4, 8 or 16 h following a single s.c. injection of
estradiol-17
(estradiol, 1 mg). Ovaries from each animal were incubated individually: one in the
presence of LH (10 µg/ml) for 4 h, the other with progesterone-4-[14C] (10-6 M) for 2 h. For the
LH incubated ovaries, in vivo treatment with estradiol had no significant effect on progesterone
accumulation, whereas production of both testosterone and androstenedione was inhibited by
estradiol in a manner dependent on the duration of estradiol treatment in vivo. Analysis of the
conversion of radioactive progesterone to its major metabolites by the contralateral ovaries revealed
a time-dependent inhibition by estradiol in the formation of androstenedione, 5
-androstanedione
and androsterone, whereas the production of 5
-pregnanedione and 3
-OH-5
-pregnan-20-one was
significantly stimulated, also in a time-dependent manner. In another experiment, in vivo stimulation for 1 h with LH produced alterations in the pattern of metabolites of progesterone-4-[14C]
identical to those found upon treatment with estradiol; both treatments resulted in a marked
stimulation of 3
-OH-5
-pregnan-20-one, accompanied by an inhibition, of similar magnitude,
of production of androsterone. These results suggest that 1) estradiol may act to inhibit ovarian
androgen production by impairing the C17
-hydroxylase/C17,20-lyase enzyme systems, thereby
diverting C21-substrates through alternate metabolic pathways leading to accumulation of 5
-pregnane compounds and 2) the inhibitory action of LH upon ovarian androgen production may
be mediated by estrogen.
Note:
ACKNOWLEDGMENTS
We thank the Hormone Distribution Office, NIH,
Bethesda, MD, for donating the luteinizing hormone
(NIH-LH-B8), Dr. D. K. Pomerantz for determination
of the serum levels of LH and FSH, Dr. J. Zamecnik
and Mr. G. Barbe for the preparation of the antibody
and validation of the radioimmunoassay for androstenedione and Dr. T. G. Kennedy for advice with
statistical analysis.
This article has been cited by other articles:
![]() |
S. Stefanczyk-Krzymowska, B. Wasowska, J. Chlopek, and W. Grzegorzewski Retrograde transfer of steroid hormones to the ovary in luteal and follicular phases of porcine oestrous cycle in vivo Exp Physiol, January 1, 2004; 89(1): 140 - 144. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |